Los Angeles Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.68M Buy
21,817
+967
+5% +$75.5K 0.01% 543
2025
Q4
$1.92M Buy
20,850
+1,040
+5% +$90K 0.01% 456
2025
Q3
$1.81M Buy
19,810
+5,297
+36% +$432K 0.01% 531
2025
Q2
$947K Sell
14,513
-4,410
-23% -$287K ﹤0.01% 658
2025
Q1
$1.27M Sell
18,923
-651
-3% -$38.9K 0.01% 501
2024
Q4
$1.08M Sell
19,574
-1,900
-9% -$109K ﹤0.01% 595
2024
Q3
$1.28M Sell
21,474
-1,500
-7% -$91.5K 0.01% 562
2024
Q2
$1.46M Sell
22,974
-2,000
-8% -$130K 0.01% 527
2024
Q1
$1.73M Buy
24,974
+5,408
+28% +$326K 0.01% 535
2023
Q4
$1.08M Sell
19,566
-129
-0.7% -$7.1K ﹤0.01% 652
2023
Q3
$1.14M Sell
19,695
-13,209
-40% -$762K ﹤0.01% 600
2023
Q2
$1.77M Buy
+32,904
New +$1.46M 0.01% 521

Other funds holding ANIP